GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
111 hedge funds and large institutions have $54.3M invested in Sanofi Contingent Value Rights in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
56% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 16
Holders
111
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$239K | |
| 2 | +$42.8K | |
| 3 | +$13.2K | |
| 4 |
Goldman Sachs
New York
|
+$7.63K |
| 5 |
Bank of New York Mellon
New York
|
+$4.47K |
Top Sellers
| 1 | -$36.9K | |
| 2 | -$19K | |
| 3 | -$8.86K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8.05K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.04K |